STCBIO

STRI (STC STEM CELL TREATMENT & RESEARCH INSTITUTE) discovered world's first pluripotent stem cell without side effects or STC-nEPS (newly Elicited Pluripotent Stem Cell without side effects) that is also mass producible and immediately applicable on human body. STRI has applied and is registering 453 patents in 147 countries.

Also known as: STC Group, STC Group Co.,Ltd, STC Group Corporation Co.Ltd

Primary location: Seoul South Korea